WHO classification of haematolymphoid tumours
Updates to Article Attributes
Body
was changed:
The World Health Organizatiοn (WHO) classification of tumours of hematopoietichaematopoietic and lymphoid tissues is the most widely used pathologic classification system for hematolymphoid neoplasms. The current revision, known as the 4th revised edition, was published in 2016 and supersedes the 4th edition published in 2008.
The 2016 version forms the basis of the article below 1-3.
Classification
Myeloid neoplasms
-
myeloproliferative neoplasms
-
chronic myeloid
leukemialeukaemia, BCR-ABL1-positive - chronic neutrophilic
leukemialeukaemia polycythemiapolycythaemia vera- primary myelofibrosis
- essential
thrombocythemiathrombocythaemia - chronic eosinophilic
leukemialeukaemia, not otherwise specified - myeloproliferative neoplasm, unclassifiable
-
chronic myeloid
-
mastocytosis
- cutaneous mastocytosis
- systemic mastocytosis
- indolent systemic mastocytosis
-
smolderingsmouldering systemic mastocytosis - systemic mastocytosis with an associated
hematologicalhaematological neoplasm - aggressive systemic mastocytosis
- mast cell
leukemialeukaemia
- mast cell sarcoma
- myeloid/lymphoid neoplasms with eosinophilia and gene rearrangement
- myeloid/lymphoid neoplasms with PDGFRA rearrangement
- myeloid/lymphoid neoplasms with PDGFRB rearrangement
- myeloid/lymphoid neoplasms with FGFR1 rearrangement
- myeloid/lymphoid neoplasms with PCM1-JAK2 (provisional entity)
- myelodysplastic/myeloproliferative neoplasms
- chronic myelomonocytic
leukemialeukaemia - atypical chronic myeloid
leukemialeukaemia, BCR-ABL1-negative - juvenile myelomonocytic
leukemialeukaemia - myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis
- myelodysplastic/myeloproliferative neoplasm, unclassifiable
- chronic myelomonocytic
-
myelodysplastic syndromes
- myelodysplastic syndrome with single lineage dysplasia
- myelodysplastic syndrome with multilineage dysplasia
- myelodysplastic syndrome with ring sideroblasts
- myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia
- myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia
- myelodysplastic syndrome with excess blasts
- myelodysplastic syndrome with isolated del(5q)
- myelodysplastic syndrome, unclassifiable
- refractory cytopenia of childhood (provisional entity)
- myeloid neoplasms with germline predisposition
- myeloid neoplasms with germline predisposition without a preexisting disorder or organ dysfunction
- acute myeloid
leukemialeukaemia with germline CEBPA mutation - myeloid neoplasms with germline DDX41 mutation
- acute myeloid
- myeloid neoplasms with germline predisposition and preexisting platelet disorders
- myeloid neoplasms with germline RUNX1 mutation
- myeloid neoplasms with germline ANKRD26 mutation
- myeloid neoplasms with germline ETV6 mutation
- myeloid neoplasms with germline predisposition and other organ dysfunction
- myeloid neoplasms with germline GATA2 mutation
- myeloid neoplasms associated with bone marrow failure syndromes
- myeloid neoplasms associated with telomere biology disorders
- juvenile myelomonocytic
leukemialeukaemia associated with neurofibromatosis, Noonan syndrome or Noonan syndrome-like disorders - myeloid neoplasms associated with Down syndrome
- myeloid neoplasms with germline predisposition without a preexisting disorder or organ dysfunction
-
acute myeloid leukaemia and related neoplasms
- acute myeloid
leukemialeukaemia with recurrent genetic abnormalities- acute myeloid
leukemialeukaemia with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 - acute myeloid
leukemialeukaemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 - acute promyelocytic leukaemia with PML-RARA
- acute myeloid
leukemialeukaemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A - acute myeloid
leukemialeukaemia with t(6;9)(p23;q34.1); DEK-NUP214 - acute myeloid
leukemialeukaemia with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM - acute myeloid
leukemialeukaemia (megakaryoblastic) with t(1;22)(p13.3;q13.3); RBM15-MKL1 - acute myeloid
leukemialeukaemia with BCR-ABL1 (provisional entity) - acute myeloid
leukemialeukaemia with mutated NPM1 - acute myeloid
leukemialeukaemia with biallelic mutations of CEBPA - acute myeloid
leukemialeukaemia with mutated RUNX1 (provisional entity)
- acute myeloid
- acute myeloid
leukemialeukaemia with myelodysplasia-related changes - therapy-related myeloid neoplasms
- acute myeloid
leukemialeukaemia, not otherwise specified- acute myeloid
leukemialeukaemia with minimal differentiation - acute myeloid
leukemialeukaemia without maturation - acute myeloid
leukemialeukaemia with maturation - acute myelomonocytic
leukemialeukaemia - acute monoblastic/monocytic
leukemialeukaemia - pure erythroid
leukemialeukaemia - acute megakaryoblastic
leukemialeukaemia - acute basophilic
leukemialeukaemia - acute panmyelosis with myelofibrosis
- acute myeloid
- myeloid sarcoma
- myeloid proliferations related to Down syndrome
- transient abnormal myelopoiesis
- myeloid
leukemialeukaemia associated with Down syndrome
- acute myeloid
- blastic plasmacytoid dendritic cell neoplasm
- acute leukemias of ambiguous lineage
- acute undifferentiated
leukemialeukaemia - mixed phenotype acute
leukemialeukaemia with t(9;22)(q34.1;q11.2); BCR-ABL1 - mixed phenotype acute
leukemialeukaemia with t(v;11q23.3); KMT2A rearranged - mixed phenotype acute
leukemialeukaemia, B/myeloid, not otherwise specified - mixed phenotype acute
leukemialeukaemia, T/myeloid, not otherwise specified
- acute undifferentiated
Lymphoid neoplasms
-
precursor lymphoid neoplasms
- B-lymphoblastic
leukemialeukaemia/lymphoma- B-lymphoblastic
leukemialeukaemia/lymphoma, not otherwise specified - B-lymphoblastic
leukemialeukaemia/lymphoma with recurrent genetic abnormalities- B-lymphoblastic
leukemialeukaemia/lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1 - B-lymphoblastic
leukemialeukaemia/lymphoma with t(v;11q23.3); KMT2A rearranged - B-lymphoblastic
leukemialeukaemia/lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1 - B-lymphoblastic
leukemialeukaemia/lymphoma with hyperdiploidy - B-lymphoblastic
leukemialeukaemia/lymphoma with hypodiploidy - B-lymphoblastic
leukemialeukaemia/lymphoma with t(5;14)(q31.1;q32.3); IL3-IGH - B-lymphoblastic
leukemialeukaemia/lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1 - B-lymphoblastic
leukemialeukaemia/lymphoma, BCR-ABL1–like (provisional entity) - B-lymphoblastic
leukemialeukaemia/lymphoma with iAMP21 (provisional entity)
- B-lymphoblastic
- B-lymphoblastic
- T-lymphoblastic
leukemialeukaemia/lymphoma- early T-cell precursor lymphoblastic
leukemialeukaemia (provisional entity)
- early T-cell precursor lymphoblastic
- natural killer (NK) cell lymphoblastic
leukemialeukaemia/lymphoma (provisional entity)
- B-lymphoblastic
- mature B-cell neoplasms
-
chronic lymphocytic
leukemialeukaemia/small lymphocytic lymphoma - monoclonal B-cell lymphocytosis
- B-cell prolymphocytic
leukemialeukaemia - splenic marginal zone lymphoma
- hairy cell
leukemialeukaemia -
splenic B-cell lymphoma
/leukemia/leukaemia, unclassifiable- splenic diffuse red pulp small B-cell lymphoma (provisional entity)
- hairy cell
leukemialeukaemia-variant (provisional entity)
- lymphoplasmacytic lymphoma
- IgM monoclonal gammopathy of undetermined significance
- heavy-chain diseases
- μ heavy-chain disease
- γ heavy-chain disease
- α heavy-chain disease
- plasma cell neoplasms
- non-IgM monoclonal gammopathy of undetermined significance (IgG/A)
- plasma cell myeloma (a.k.a. multiple myeloma)
- plasma cell myeloma variants
- plasmacytoma
- monoclonal immunoglobulin deposition diseases
- primary amyloidosis
- light chain and heavy chain deposition diseases
- plasma cell neoplasms with associated paraneoplastic syndrome
- POEMS syndrome
- TEMPI syndrome
- extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)
- nodal marginal zone lymphoma
-
pediatricpaediatric nodal marginal zone lymphoma (provisional entity)
-
-
follicular lymphoma
- testicular follicular lymphoma
- in situ follicular neoplasia
- duodenal-type follicular lymphoma
-
pediatricpaediatric-type follicular lymphoma - large B-cell lymphoma with IRF4 rearrangement (provisional entity)
- primary cutaneous follicle
centercentre lymphoma -
mantle cell lymphoma
-
leukemicleukaemic non-nodal mantle cell lymphoma - in situ mantle cell neoplasia
-
- diffuse large B-cell lymphoma, not otherwise specified
- germinal
centercentre B-cell type - activated B-cell type
- germinal
- T-cell/histiocyte-rich large B-cell lymphoma
- primary diffuse large B-cell lymphoma of the central nervous system
- primary cutaneous diffuse large B-cell lymphoma, leg type
- EBV-positive diffuse large B-cell lymphoma, not otherwise specified
- EBV-positive mucocutaneous ulcer (provisional entity)
- diffuse large B-cell lymphoma associated with chronic inflammation
- fibrin-associated diffuse large B-cell lymphoma
- lymphomatoid granulomatosis
- primary mediastinal (thymic) large B-cell lymphoma
- intravascular large B-cell lymphoma
- ALK-positive large B-cell lymphoma
- plasmablastic lymphoma
- primary effusion lymphoma
- HHV8-associated lymphoproliferative disorders
- multicentric Castleman disease
- HHV8-positive diffuse large B-cell lymphoma, not otherwise specified (provisional entity)
- HHV8-positive germinotropic lymphoproliferative disorder
- Burkitt lymphoma
- Burkitt-like lymphoma with 11q aberration (provisional entity)
- high-grade B-cell lymphoma
- high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements
- high-grade B-cell lymphoma, not otherwise specified
- B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma
-
chronic lymphocytic
- mature T- and NK-cell neoplasms
- T-cell prolymphocytic
leukemialeukaemia - T-cell large granular lymphocytic
leukemialeukaemia - chronic lymphoproliferative disorder of NK cells (provisional entity)
- aggressive NK-cell
leukemialeukaemia - EBV-positive T-cell and NK-cell lymphoproliferative diseases of childhood
- systemic EBV-positive T-cell lymphoma of childhood
- chronic active EBV infection of T- and NK-cell type, systemic form
- hydroa vacciniforme–like lymphoproliferative disorder
- severe mosquito bite allergy
- adult T-cell
leukemialeukaemia/lymphoma - extranodal NK-/T-cell lymphoma, nasal type
- intestinal T-cell lymphoma
- enteropathy-associated T-cell lymphoma
- monomorphic epitheliotropic intestinal T-cell lymphoma
- intestinal T-cell lymphoma, not otherwise specified
- indolent T-cell lymphoproliferative disorder of the gastrointestinal tract (provisional entity)
- hepatosplenic T-cell lymphoma
- subcutaneous panniculitis-like T-cell lymphoma
- mycosis fungoides
- Sézary syndrome
- primary cutaneous CD30+ T-cell lymphoproliferative disorders
- lymphomatoid papulosis
- primary cutaneous anaplastic large cell lymphoma
- primary cutanoue peripheral T-cell lymphomas, rare subtypes
- primary cutaneous γδ T-cell lymphoma
- primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma (provisional entity)
- primary cutaneous acral CD8+ T-cell lymphoma (provisional entity)
- primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder (provisional entity)
- peripheral T-cell lymphoma, not otherwise specified
- angioimmunoblastic T-cell lymphoma and other nodal lymphomas of T follicular helper cell origin
- angioimmunoblastic T-cell lymphoma
- follicular T-cell lymphoma (provisional entity)
- nodal peripheral T-cell lymphoma with T follicular helperphenotype (provisional entity)
- anaplastic large-cell lymphoma
- breast implant-associated anaplastic large-cell lymphoma (provisional entity)
- T-cell prolymphocytic
-
Hodgkin lymphoma
- nodular lymphocyte predominant Hodgkin lymphoma
- classical Hodgkin lymphoma
- nodular sclerosis classical Hodgkin lymphoma
- lymphocyte-rich classical Hodgkin lymphoma
- mixed cellularity classical Hodgkin lymphoma
- lymphocyte-depleted classical Hodgkin lymphoma
-
posttransplant lymphoproliferative disorders (PTLD)
- plasmacytic hyperplasia PTLD
- infectious mononucleosis PTLD
- florid follicular hyperplasia PTLD
- polymorphic PTLD
- monomorphic PTLD
- monomorphic B-cell PTLD
- monomorphic T/NK-cell PTLD
- classical Hodgkin lymphoma PTLD
Histiocytic and dendritic cell neoplasms
- histiocytic sarcoma
-
tumorstumours derived from Langerhans cells - indeterminate dendritic cell
tumortumour - interdigitating dendritic cell sarcoma
- follicular dendritic cell sarcoma
- inflammatory
pseudotumorpseudotumour-like follicular/fibroblastic dendritic cell sarcoma
- inflammatory
- fibroblastic reticular cell
tumortumour - disseminated juvenile xanthogranuloma
- Erdheim-Chester disease
See also
-<p>The<strong> World Health Organizatiοn (WHO) classification of tumours of hematopoietic and lymphoid tissues</strong> is the most widely used pathologic classification system for hematolymphoid neoplasms. The current revision, known as the 4<sup>th</sup> revised edition, was published in 2016 and supersedes the 4<sup>th </sup>edition published in 2008.</p><p>The 2016 version forms the basis of the article below <sup>1-</sup><sup>3</sup>.</p><h4>Classification</h4><h5>Myeloid neoplasms</h5><ul>- +<p>The<strong> World Health Organizatiοn (WHO) classification of tumours of haematopoietic and lymphoid tissues</strong> is the most widely used pathologic classification system for hematolymphoid neoplasms. The current revision, known as the 4<sup>th</sup> revised edition, was published in 2016 and supersedes the 4<sup>th </sup>edition published in 2008.</p><p>The 2016 version forms the basis of the article below <sup>1-</sup><sup>3</sup>.</p><h4>Classification</h4><h5>Myeloid neoplasms</h5><ul>
-<a href="/articles/chronic-myeloid-leukaemia">chronic myeloid leukemia</a>, <em>BCR-ABL1</em>-positive</li>-<li><a href="/articles/chronic-neutrophilic-leukemia">chronic neutrophilic leukemia</a></li>-<li><a href="/articles/polycythaemia-vera">polycythemia vera</a></li>- +<a href="/articles/chronic-myeloid-leukaemia">chronic myeloid leukaemia</a>, <em>BCR-ABL1</em>-positive</li>
- +<li><a href="/articles/chronic-neutrophilic-leukemia">chronic neutrophilic leukaemia</a></li>
- +<li><a href="/articles/polycythaemia-vera">polycythaemia vera</a></li>
-<li><a href="/articles/essential-thrombocythemia">essential thrombocythemia</a></li>-<li>chronic eosinophilic leukemia, not otherwise specified</li>- +<li><a href="/articles/essential-thrombocythemia">essential thrombocythaemia</a></li>
- +<li>chronic eosinophilic leukaemia, not otherwise specified</li>
-<li>smoldering systemic mastocytosis</li>-<li>systemic mastocytosis with an associated hematological neoplasm</li>- +<li>smouldering systemic mastocytosis</li>
- +<li>systemic mastocytosis with an associated haematological neoplasm</li>
-<li>mast cell leukemia</li>- +<li>mast cell leukaemia</li>
-<li><a href="/articles/chronic-myelomonocytic-leukaemia">chronic myelomonocytic leukemia</a></li>-<li>atypical chronic myeloid leukemia, <em>BCR-ABL1</em>-negative</li>-<li>juvenile myelomonocytic leukemia</li>- +<li><a href="/articles/chronic-myelomonocytic-leukaemia">chronic myelomonocytic leukaemia</a></li>
- +<li>atypical chronic myeloid leukaemia, <em>BCR-ABL1</em>-negative</li>
- +<li>juvenile myelomonocytic leukaemia</li>
-<li>acute myeloid leukemia with germline <em>CEBPA </em>mutation</li>- +<li>acute myeloid leukaemia with germline <em>CEBPA </em>mutation</li>
-<li>juvenile myelomonocytic leukemia associated with <a href="/articles/neurofibromatosis">neurofibromatosis</a>, <a href="/articles/noonan-syndrome">Noonan syndrome</a> or Noonan syndrome-like disorders</li>- +<li>juvenile myelomonocytic leukaemia associated with <a href="/articles/neurofibromatosis">neurofibromatosis</a>, <a href="/articles/noonan-syndrome">Noonan syndrome</a> or Noonan syndrome-like disorders</li>
-<li>acute myeloid leukemia with recurrent genetic abnormalities<ul>-<li>acute myeloid leukemia with t(8;21)(q22;q22.1); <em>RUNX1-RUNX1T1</em>- +<li>acute myeloid leukaemia with recurrent genetic abnormalities<ul>
- +<li>acute myeloid leukaemia with t(8;21)(q22;q22.1); <em>RUNX1-RUNX1T1</em>
-<li>acute myeloid leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); <em>CBFB-MYH11</em>- +<li>acute myeloid leukaemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); <em>CBFB-MYH11</em>
-<li>acute myeloid leukemia with t(9;11)(p21.3;q23.3); <em>MLLT3-KMT2A</em>- +<li>acute myeloid leukaemia with t(9;11)(p21.3;q23.3); <em>MLLT3-KMT2A</em>
-<li>acute myeloid leukemia with t(6;9)(p23;q34.1); <em>DEK-NUP214</em>- +<li>acute myeloid leukaemia with t(6;9)(p23;q34.1); <em>DEK-NUP214</em>
-<li>acute myeloid leukemia with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); <em>GATA2</em>, <em>MECOM</em>- +<li>acute myeloid leukaemia with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); <em>GATA2</em>, <em>MECOM</em>
-<li>acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13.3;q13.3); <em>RBM15-MKL1</em>- +<li>acute myeloid leukaemia (megakaryoblastic) with t(1;22)(p13.3;q13.3); <em>RBM15-MKL1</em>
-<li>acute myeloid leukemia with <em>BCR-ABL1</em> (provisional entity)</li>-<li>acute myeloid leukemia with mutated <em>NPM1</em>- +<li>acute myeloid leukaemia with <em>BCR-ABL1</em> (provisional entity)</li>
- +<li>acute myeloid leukaemia with mutated <em>NPM1</em>
-<li>acute myeloid leukemia with biallelic mutations of <em>CEBPA</em>- +<li>acute myeloid leukaemia with biallelic mutations of <em>CEBPA</em>
-<li>acute myeloid leukemia with mutated <em>RUNX1 </em>(provisional entity)</li>- +<li>acute myeloid leukaemia with mutated <em>RUNX1 </em>(provisional entity)</li>
-<li>acute myeloid leukemia with myelodysplasia-related changes</li>- +<li>acute myeloid leukaemia with myelodysplasia-related changes</li>
-<li>acute myeloid leukemia, not otherwise specified<ul>-<li>acute myeloid leukemia with minimal differentiation</li>-<li>acute myeloid leukemia without maturation</li>-<li>acute myeloid leukemia with maturation</li>-<li>acute myelomonocytic leukemia</li>-<li>acute monoblastic/monocytic leukemia</li>-<li>pure erythroid leukemia</li>-<li>acute megakaryoblastic leukemia</li>-<li>acute basophilic leukemia</li>- +<li>acute myeloid leukaemia, not otherwise specified<ul>
- +<li>acute myeloid leukaemia with minimal differentiation</li>
- +<li>acute myeloid leukaemia without maturation</li>
- +<li>acute myeloid leukaemia with maturation</li>
- +<li>acute myelomonocytic leukaemia</li>
- +<li>acute monoblastic/monocytic leukaemia</li>
- +<li>pure erythroid leukaemia</li>
- +<li>acute megakaryoblastic leukaemia</li>
- +<li>acute basophilic leukaemia</li>
-<li>myeloid leukemia associated with Down syndrome</li>- +<li>myeloid leukaemia associated with Down syndrome</li>
-<li>acute undifferentiated leukemia</li>-<li>mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2);<em> BCR-ABL1</em>- +<li>acute undifferentiated leukaemia</li>
- +<li>mixed phenotype acute leukaemia with t(9;22)(q34.1;q11.2);<em> BCR-ABL1</em>
-<li>mixed phenotype acute leukemia with t(v;11q23.3); <em>KMT2A </em>rearranged</li>-<li>mixed phenotype acute leukemia, B/myeloid, not otherwise specified</li>-<li>mixed phenotype acute leukemia, T/myeloid, not otherwise specified</li>- +<li>mixed phenotype acute leukaemia with t(v;11q23.3); <em>KMT2A </em>rearranged</li>
- +<li>mixed phenotype acute leukaemia, B/myeloid, not otherwise specified</li>
- +<li>mixed phenotype acute leukaemia, T/myeloid, not otherwise specified</li>
-<li>B-lymphoblastic leukemia/lymphoma<ul>-<li>B-lymphoblastic leukemia/lymphoma, not otherwise specified</li>-<li>B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormalities<ul>-<li>B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2); <em>BCR-ABL1</em>- +<li>B-lymphoblastic leukaemia/lymphoma<ul>
- +<li>B-lymphoblastic leukaemia/lymphoma, not otherwise specified</li>
- +<li>B-lymphoblastic leukaemia/lymphoma with recurrent genetic abnormalities<ul>
- +<li>B-lymphoblastic leukaemia/lymphoma with t(9;22)(q34.1;q11.2); <em>BCR-ABL1</em>
-<li>B-lymphoblastic leukemia/lymphoma with t(v;11q23.3); <em>KMT2A</em> rearranged</li>-<li>B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1); <em>ETV6-RUNX1</em>- +<li>B-lymphoblastic leukaemia/lymphoma with t(v;11q23.3); <em>KMT2A</em> rearranged</li>
- +<li>B-lymphoblastic leukaemia/lymphoma with t(12;21)(p13.2;q22.1); <em>ETV6-RUNX1</em>
-<li>B-lymphoblastic leukemia/lymphoma with hyperdiploidy</li>-<li>B-lymphoblastic leukemia/lymphoma with hypodiploidy</li>-<li>B-lymphoblastic leukemia/lymphoma with t(5;14)(q31.1;q32.3); <em>IL3-IGH</em>- +<li>B-lymphoblastic leukaemia/lymphoma with hyperdiploidy</li>
- +<li>B-lymphoblastic leukaemia/lymphoma with hypodiploidy</li>
- +<li>B-lymphoblastic leukaemia/lymphoma with t(5;14)(q31.1;q32.3); <em>IL3-IGH</em>
-<li>B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3); <em>TCF3-PBX1</em>- +<li>B-lymphoblastic leukaemia/lymphoma with t(1;19)(q23;p13.3); <em>TCF3-PBX1</em>
-<li>B-lymphoblastic leukemia/lymphoma, <em>BCR-ABL1</em>–like (provisional entity)</li>-<li>B-lymphoblastic leukemia/lymphoma with iAMP21 (provisional entity)</li>- +<li>B-lymphoblastic leukaemia/lymphoma, <em>BCR-ABL1</em>–like (provisional entity)</li>
- +<li>B-lymphoblastic leukaemia/lymphoma with iAMP21 (provisional entity)</li>
-<li>T-lymphoblastic leukemia/lymphoma<ul><li>early T-cell precursor lymphoblastic leukemia (provisional entity)</li></ul>- +<li>T-lymphoblastic leukaemia/lymphoma<ul><li>early T-cell precursor lymphoblastic leukaemia (provisional entity)</li></ul>
-<li>natural killer (NK) cell lymphoblastic leukemia/lymphoma (provisional entity)</li>- +<li>natural killer (NK) cell lymphoblastic leukaemia/lymphoma (provisional entity)</li>
-<a href="/articles/chronic-lymphocytic-leukaemia">chronic lymphocytic leukemia</a>/<a href="/articles/small-lymphocytic-lymphoma">small lymphocytic lymphoma</a>- +<a href="/articles/chronic-lymphocytic-leukaemia">chronic lymphocytic leukaemia</a>/<a href="/articles/small-lymphocytic-lymphoma">small lymphocytic lymphoma</a>
-<li>B-cell prolymphocytic leukemia</li>- +<li>B-cell prolymphocytic leukaemia</li>
-<li><a href="/articles/hairy-cell-leukemia">hairy cell leukemia</a></li>- +<li><a href="/articles/hairy-cell-leukemia">hairy cell leukaemia</a></li>
-<a href="/articles/splenic-lymphoma">splenic B-cell lymphoma/leukemia, unclassifiable</a><ul>- +<a href="/articles/splenic-lymphoma">splenic B-cell lymphoma/leukaemia, unclassifiable</a><ul>
-<li>hairy cell leukemia-variant (provisional entity)</li>- +<li>hairy cell leukaemia-variant (provisional entity)</li>
-<li>lymphoplasmacytic lymphoma<ul><li><a href="/articles/waldenstrom-macroglobulinaemia">Waldenström macroglobulinemia</a></li></ul>- +<li>
- +<a title="lymphoplasmacytic lymphoma" href="/articles/lymphoplasmacytic-lymphoma">lymphoplasmacytic lymphoma</a><ul><li><a href="/articles/waldenstrom-macroglobulinaemia">Waldenström macroglobulinaemia</a></li></ul>
-<li><a href="/articles/smouldering-multiple-myeloma">smoldering (asymptomatic) plasma cell myeloma</a></li>- +<li><a href="/articles/smouldering-multiple-myeloma">smouldering (asymptomatic) plasma cell myeloma</a></li>
-<li><a href="/articles/plasma-cell-leukemia">plasma cell leukemia</a></li>- +<li><a href="/articles/plasma-cell-leukemia">plasma cell leukaemia</a></li>
-<li>nodal <a href="/articles/marginal-zone-lymphoma">marginal zone lymphoma</a><ul><li>pediatric nodal marginal zone lymphoma (provisional entity)</li></ul>- +<li>nodal <a href="/articles/marginal-zone-lymphoma">marginal zone lymphoma</a><ul><li>paediatric nodal marginal zone lymphoma (provisional entity)</li></ul>
-<li>pediatric-type follicular lymphoma</li>- +<li>paediatric-type follicular lymphoma</li>
-<li>primary cutaneous follicle center lymphoma</li>- +<li>primary cutaneous follicle centre lymphoma</li>
-<li>leukemic non-nodal mantle cell lymphoma</li>- +<li>leukaemic non-nodal mantle cell lymphoma</li>
-<li>germinal center B-cell type</li>- +<li>germinal centre B-cell type</li>
-<li><a href="/articles/t-cell-prolymphocytic-leukaemia-1">T-cell prolymphocytic leukemia</a></li>-<li>T-cell large granular lymphocytic leukemia</li>- +<li><a href="/articles/t-cell-prolymphocytic-leukaemia-1">T-cell prolymphocytic leukaemia</a></li>
- +<li>T-cell large granular lymphocytic leukaemia</li>
-<li>aggressive NK-cell leukemia</li>- +<li>aggressive NK-cell leukaemia</li>
-<li>adult T-cell leukemia/lymphoma</li>- +<li>adult T-cell leukaemia/lymphoma</li>
-<a title="peripheral T-cell lymphoma" href="/articles/peripheral-t-cell-lymphoma">peripheral T-cell lymphoma</a>, not otherwise specified</li>- +<a href="/articles/peripheral-t-cell-lymphoma">peripheral T-cell lymphoma</a>, not otherwise specified</li>
-<li>tumors derived from Langerhans cells<ul>- +<li>tumours derived from Langerhans cells<ul>
-<li>indeterminate dendritic cell tumor</li>- +<li>indeterminate dendritic cell tumour</li>
-<li>follicular dendritic cell sarcoma<ul><li>inflammatory pseudotumor-like follicular/fibroblastic dendritic cell sarcoma</li></ul>- +<li>follicular dendritic cell sarcoma<ul><li>inflammatory pseudotumour-like follicular/fibroblastic dendritic cell sarcoma</li></ul>
-<li>fibroblastic reticular cell tumor</li>- +<li>fibroblastic reticular cell tumour</li>
Unable to process the form. Check for errors and try again.